Table 4 Baseline characteristics and outcome data in COVID-19 cases and matched controls.
From: The impact of COVID-19 on pregnancy outcomes in a diverse cohort in England
COVID-19 cases (n = 214) | Controls (n = 214) | p value | |
|---|---|---|---|
Baseline Characteristics | |||
Maternal age (years) | 30 (26–34) | 30 (26–34) | 0.91 |
Ethnicity | |||
Asian | 65 (30.4%) | 65 (30.4%) | – |
Black | 37 (17.3%) | 37 (17.3%) | – |
Mixed | 2 (0.9%) | 2 (0.9%) | – |
Other | 19 (8.9%) | 19 (8.9%) | – |
White | 89 (41.6%) | 89 (41.6%) | – |
Not recorded | 2 (0.9%) | 2 (0.9%) | – |
Parity | 1 (0–2) | 1 (0–2) | 0.30 |
BMI (kg/m2) | 27.3 ± 6.1 | 27.1 ± 6.3 | 0.46 |
Diabetes in pregnancy | 17 (7.9%) | 17 (7.9%) | – |
Hypertension at booking | 7 (3.3%) | 7 (3.3%) | – |
Sex of baby | |||
Male | 119 (55.6%) | 118 (55.1%) | 0.60 |
Female | 94 (43.9%) | 96 (44.9%) | |
Indeterminate | 1 (0.5%) | 0 (0.0%) | |
Trimester at diagnosis | |||
First | 3 (1.4%) | – | – |
Second | 25 (11.7%) | – | – |
Third | 186 (86.9%) | – | – |
Neonatal Outcomes | |||
Mode of delivery | |||
Spontaneous vaginal | 105 (49.1%) | 114 (53.3%) | 0.70 |
Forceps | 26 (12.2%) | 30 (14.0%) | |
Ventouse | 10 (4.7%) | 8 (3.7%) | |
Emergency CS | 46 (21.5%) | 41 (19.2%) | |
Elective CS | 27 (12.6%) | 21 (9.8%) | |
Gestation at delivery (days) | 275 (269–281) | 278 (271–284) | 0.002 |
Preterm birth | |||
< 37 weeks | 27 (12.6%) | 18 (8.4%) | 0.16 |
< 34 weeks | 7 (3.3%) | 3 (1.4%) | 0.20 |
Iatrogenic (< 37 weeks) | 21 (9.8%) | 9 (4.2%) | 0.02 |
Placental abruption | 3 (1.4%) | 1 (0.5%) | N/Aa |
Stillbirth | 1 (0.5%) | 0 (0.0%) | N/Aa |
Neonatal death | 2 (0.9%) | 2 (0.9%) | N/Aa |
NICU admission | 25 (11.7%) | 30 (14.0%) | 0.48 |
NICU length of stay (days) | 6 (3–12) (n = 25) | 3.5 (2–8) (n = 30) | 0.25 |
Cord arterial pH | 7.18 ± 0.09 (n = 82) | 7.18 ± 0.08 (n = 98) | 0.49 |
Cord arterial base deficit | 7.0 ± 3.7 (n = 82) | 7.4 ± 3.6 (n = 98) | 0.75 |
Maternal Outcomes | |||
Estimated blood loss (ml) | 400 (300–700) | 450 (300–700) | 0.39 |
Maternal length of stay (days) | 2 (1–4) | 2 (1–4) | 0.81 |
Pre-eclampsia | 6 (2.8%) | 8 (3.7%) | 0.60 |
HDU admission | 12 (5.6%) | 12 (5.6%) | 1.00 |
ICU admission | 4 (1.9%) | 0 (0.0%) | N/Aa |
COVID-19 Cases (n = 91b) | Controls (n = 91b) | Significance (p value) | |
|---|---|---|---|
Growth | |||
Birth weight (g) | 3244 ± 616 | 3351 ± 584 | 0.12 |
Birth weight z-score | − 0.29 ± 1.20 | − 0.36 ± 1.16 | 0.66 |
Fetal growth restriction | 8 (8.8%) | 9 (9.9%) | 0.80 |